MARSHALL WACE, LLP - PLX PHARMA INC ownership

PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 63 filers reported holding PLX PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of PLX PHARMA INC
ValueSharesWeighting
Q2 2022$98,000
+10.1%
40,154
+262.3%
0.00%
Q4 2021$89,000
-91.8%
11,084
-80.4%
0.00%
-100.0%
Q3 2021$1,091,000
-80.9%
56,528
-86.4%
0.01%
-80.8%
Q2 2021$5,716,000
+138.4%
414,186
+56.0%
0.03%
+136.4%
Q1 2021$2,398,000265,4620.01%
Other shareholders
PLX PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 62,673$254,0000.31%
Park West Asset Management LLC 1,075,723$4,357,0000.16%
Harel Insurance Investments & Financial Services Ltd. 550,000$2,228,0000.11%
CVI Holdings, LLC 13,878$56,0000.09%
Heritage Way Advisors, LLC 12,000$49,0000.03%
Cranbrook Wealth Management, LLC 7,500$30,0000.01%
BROWN ADVISORY INC 75,000$304,0000.00%
WELLS FARGO & COMPANY/MN 11,000$45,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 86,209$349,0000.00%
View complete list of PLX PHARMA INC shareholders